Chicago Opera Theater Announces New Season | Playbill

News Chicago Opera Theater Announces New Season Stewart Copeland and Philip Glass are among the composers featured in the 2016-17 slate.
Steve Pyke

Chicago Opera Theater has announced its 2016-17 season. The new slate will feature a co-premiere of The Invention of Morel, a new work by the composer and co-founder of rock band The Police, Stewart Copeland; as well as the Chicago premiere of The Perfect American, Philip Glass’ fictionalized biography of Walt Disney’s life.

The season will kick off September 30 with Le Vin Herbé, Frank Martin’s 1940 opera that tells the story of Tristan and Isolde. Performances will also be presented October 7 and 9. In November, the theatre will present The Fairy Queen, Henry Purcell’s mystical take on Midsummer Night’s Dream. Performances are set to run November 5, 11 and 13.

The season continues in 2017 with Copeland’s The Invention of Morel, with a libretto and direction by Jonathan Moore. The piece is co-commissioned and will co-premiere at Chicago Opera Theater and Long Beach Opera. The new work is based on La Invención de Morel, a 1940 novel by South American author Adolfo Bioy Casares.

“Stewart is a refreshing new voice for the opera stage,” commented Andreas Mitisek, artistic and general director of Long Beach Opera and Chicago Opera Theater in an online statement. “We are thrilled to develop this time-bending love story.” The Invention of Morel is billed as a story “that shows love can bring people together in ways much greater than themselves.” Performances will run February 18, 24 and 26, 2017.

The season will conclude with the Chicago premiere of Glass’ The Perfect American, which chronicles Walt Disney’s life through the acclaimed composer’s lens. Performances will run April 22 and 30.

For more information and to purchase subscription packages, visit chicagooperatheater.org.

 
Today’s Most Popular News:
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!